Fosinopril-HCT-Mepha 20 mg/12.5 mg, Tabletten

7680583240029 CH-58324 Tabletten
Fosinopril-HCT-Mepha 20 mg/12.5 mg, Tabletten
Fosinopril-HCT-Mepha 20 mg/12.5 mg, Tabletten
Fosinopril-HCT-Mepha 20 mg/12.5 mg, Tabletten
1 / 3
google

Article details

Package size
28
Selling units
28
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
08/03/2022
Summary of Product Characteristics
Français
08/03/2022
Patient information leaflet
Allemand
07/03/2022
Patient information leaflet
Français
07/03/2022
Patient information leaflet
Italien
07/03/2022

Detailed composition

Substance Quantity Type Category
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
12.5 MG Substance Wirkstoff (Principe actif)
(N/A)
222.1 MG Substance HBESI
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
58324
Drug name
Fosinopril-HCT-Mepha, Tabletten
Galenic form
TAB
ATC Code
C09BA09
Authorization status
Z
Dispensing category
B
First authorization
15/09/2008
Authorization expiration date
01/12/2025
IT Number
02.07.2.
Domain
Human medicine
Field of application
Antihypertensivum

Package details

Description (FR)
FOSINOPRIL-HCT Mepha cpr 20/12.5 mg 28 pce
Description (DE)
FOSINOPRIL-HCT Mepha Tabl 20/12.5 mg 28 Stk
Market launch
15/09/2008
Market withdrawal
15/07/2025
Narcotic (BTM)
No

Other package sizes (3)

None
None None
GTIN: None
Not in V1
None
None None
GTIN: None
Not in V1
FOSINOPRIL-HCT Mepha cpr 20/12.5 mg 98 pce
98 TABL
GTIN: 7680583240043
View